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Abstract
Designed gene expression micro-array experiments, consisting of sev-
eral treatment levels with a number of replicates per level, are analyzed
by applying simple tests for group differences at the per gene level. The
gene level statistics are sorted and a criterion for selecting important genes
which takes into account multiplicity is applied. A caveat arises in that
true signals (genes truly over or under expressed) are “competing” with
fairly large type I error signals. False positives near the top of a sorted
list can occur when genes having very small fold-change are compensated
by small enough variance to yield a large test statistic. One of the first at-
tempts around this caveat was the development of “significance analysis of
micro-arrays (SAM)”, which used a modified t-type statistic thresholded
against its permutation distribution. The key innovation of the modified
t-statistic was the addition of a constant to the per gene standard er-
rors in order to stabilize the coefficient of variation of the resulting test
statistic. Since then, several authors have proposed the use of shrink-
age variance estimators in conjunction with t-type, and more generally,
ANOVA type tests at the gene level. Our new approach proposes the use
of a shrinkage variance Hotelling T-squared statistic in which the per gene
sample covariance matrix is replaced by a shrinkage estimate borrowing
strength from across all genes. It is demonstrated that the new statistic
retains the F-distribution under the null, with added degrees of freedom
in the denominator. Advantages of this class of tests are (i) flexibility
in that a whole family of hypothesis tests is possible (ii) the gains of the
above-mentioned earlier innovations are enjoyed more fully. This paper
summarizes our results and presents a simulation study benchmarking the
new statistic against another recently proposed statistic.
1 Introduction
Gene expression microarrays provide a fast and systematic way to identify genes
differentially expressed between two or more experimental groups of samples in
a hypothesis driven study. These samples and experimental groups could be,
for example, human prostate cancer cell line RNA samples treated with two or
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three different agents, or treated with the same agent at differing concentra-
tions. Right now cDNA chips contain on the order of ten thousand genes, while
oligonucleotide arrays contain upwards of twelve thousand genes. In the not
too distant future entire genome chips will become available. The consequence
is a tremendous savings in time and resources as the per gene expense in time
and resources for the preliminary screening of genes has gone down considerably.
Nonetheless, the considerable cost per array results in experiments that are typ-
ically based upon few replicates. For example, an experiment consisting of two
experimental conditions might have just three replicates per set of conditions.
While the shift in platfroms from cDNA arrays to oligonucleotide arrays
has resulted in the reduction in various sources of within gene and extra gene
variability, the reality is that there is still a great deal of endemic noise in these
sorts of investigations. Given the small number of replicates, power is a primary
concern. Albeit, the goal of statistical analysis in this setting is to arrive at a
relatively short list of candidate genes that warrant further investigation via a
more sensitive and specific technique such as PCR. The investigator typically
has aloted specific resources for the further investigation of a given number of
genes and will request a “short list” of the requesite length. Therefore, the role
of efficiency and power may not be completely appreciated. Clearly, however,
the goal is to present the best possible list, so that the role of efficiency and
power can now be understood.
A caveat arises in that true signals (genes truly over or under expressed) are
“competing” with fairly large type I error signals. False positives near the top
of a sorted list can occur when genes having very small fold-change are com-
pensated by small enough variance to yield a large test statistic. One of the
first attempts around this caveat was the development of “significance analysis
of micro-arrays” or (SAM), [11], which used a modified t-type statistic thresh-
olded against its permutation distribution. The key innovation of the modified
t-statistic was the addition of a constant to the per gene standard errors in order
to stabilize the coefficient of variation of the resulting test statistic. Since then,
([12], [6]) several authors have proposed the use of shrinkage variance estima-
tor in conjunction with t-type and more generally, ANOVA type tests at the
gene level. One advantage of this latter approach is that it doesn’t require the
computation of ad-hoc fudge constants. In the situation under study, e.g. a hy-
pothesis driven experiment consisting of a small number of experimental groups,
a natural model is the per gene linear model on the appropriate scale, leading to
a per gene ANOVA type test of the null. Recent work, ([12], [2], [6]), presented
a model in which the per gene residual variance parameters were considered to
be draws from an inverse gamma distribution, resulting in a “shrinkage variance
test” that could potentially have gains in efficiency depending on the hetero-
geneity of the extra gene variability. The idea of using a shrinkage estimate of
within group variance has also been persued by others such as [1], [7], and [8].
One assumption of that model which is often violated in applications is that the
extra gene variability is consistent across experimental conditions. In order to
circumvent this restrictive assumption, we extend that work to the multivariate
setting arriving now at a whole class of hypothesis tests based upon a shrinkage
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variance Hotelling T 2. If there is any appreciable between-group correlation,
this approach constitutes a more efficient use of the scarce data available per
gene data. Furthermore, as we shall point out in this work, the incorporation of
a shrinkage variance/covariance estimator into the usual Hotelling T 2 statistic
accomplishes the goals of the earlier innovations to an even greater degree.
2 Background and Motivation: Designed Gene
Expression Micro-Array experiments
The impetus for this work were two microarray studies with which the authors
have been involved. The first of these was a spotted cDNA array experiment
studying the effects of the isoflavone/phytoestrogen genestein on gene expres-
sion in the LnCAP cell line. Several batches of colonies were treated with
either 1µM, 5µM, 25µM, genestein or control media and allowed to grow for 24
hours. Messenger RNA (mRNA) isolated from each of the treated groups was
hybridized onto the green channel of a corresponding micro-array, while mRNA
isolated from the control treated colony was hybridized onto the red channel of
each micro-array. This experiment was conducted independently and in identi-
cal fashion on three separate dates. Systematic variability occuring from array
to array and within array were adjusted out in the manner suggested by [3].
Within each experimental replicate and for each gene, the log base two of the
ratio of normalized green to red channel expression values were calculated and
used in subsequent analysis. The research questions being investigated were (i)
whether there was differential expression between the green and red channels
under treatment with genestein at any of the three concentrations, and if so (ii)
was there a trend in this effect.
The second study was an oligonucleotide micro-array experiment studying
the effects of two hormones, dehydroepiandrosterone (DHEA) and dihyrotestos-
terone (DHT), on gene expression in the LnCAP line. Again, several batches
of colonies were treated with either DHEA, dhT, or control media and allowed
to grow for 24 hours. mRNA isolated from each of the two treated colonies as
well as from the control treated colony was hybridized onto one of three cor-
responding single channel oligonucleotide arrays. The raw image files, in CEL
format, were imported into the R statistical computing platform [10]. For each
gene, the probe set was summarized into a model based gene expression index
[5], using the Bioconductor suite of add-on libraries for R [4]. Within each ex-
perimental replicate and for each gene, the log base two of the expression ratios
of treatment to control were calculated and used in subsequent analysis. The
research questions here were (i) whether there was differential expression be-
tween treatment and control under treatment with either hormone, any of the
three conditions, and if so (ii) was there differential expression between the two
treatments.
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3 The Shared Hotelling T 2 statistic
As indicated in the introductory remarks above, the new methodologic tool
introduced here is a Hotelling T 2 statistic for a variety test of the null which in-
corporates a shrinkage estimate of the per gene residual variance. Suppose that
each preprocessed microarray yields expression levels on each of G genes. In the
type of studies dealt with here we have a total of n× d such microarrays arising
from n identical replicates of an experiment having d experimental conditions or
“treatments”. Here as is usually the case, the measurements being analyzed will
be the log base two of a treatment to control ratio. For each of the 1 ≤ g ≤ G
genes, we consider these measurements as an i.i.d. sequence of d-demensional
random variables, {Yg,i : i = 1, 2, . . . , ng}, where we allow the possibility that
there may be a different number of measurements for different genes due to
reading errors. We assume such missingness is completely at random. Let Y¯g
and Sg be the d-dimensional sample mean and unbiased sample covariance ma-
trix corresponding to the sample {Yg,i : i = 1, 2, . . . , ng}. Denote by Fn1,n2 and
Fn1,n2,θ the CDFs corresponding to central and non-central F−distributions,
respectively, of degrees n1 and n2, the latter having non-centrality parameter θ.
The following theorem shows that, under an assumed conjugate prior, we can
replace the estimated covariance matrix in the usual Hotelling T 2 test with a
shrinkage estimate and still retain the property that the resulting test has an F
distribution under the null hypothesis.
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Theorem 1: Suppose that ming ng > d and for a given gene, g, that
1. conditional upon Σ| g, {Yg,i : i = 1, 2, . . . , ng} is i.i.d. Nd(µ,Σ| g),
2. {Σ| g : g = 1, 2, . . . , G} is i.i.d. InvWishartd(ν,Λ) and independant of the
above.
Let T 2g = ngY¯
′
g
(
Λ + (ng − 1)Sg
)
−1
Y¯g.
Then under H0 : µ = 0d,
ShHT 2g =
ν + ng − 2d− 1
d
T 2g has the Fd,ν+ng−2d−1 distribution. (1)
The model in items 1 and 2 above is called the multivariate normal/inverse
Wishart model in the following. The above statistic has the potential for fair
sized gains in efficiency. The most ideal situation occurs when the average (over
genes) of the within gene variability is reasonably small but there is reasonable
spread across genes in the magnitude of this variation. In such a case, the
parameter Λ would not add so much magnitude to the denomenator, while the
shape parameter, ν would gives us extra degrees of freedom as if we had more
replicates per experimental condition. In reality there is trade off between these
two phenomena, and one checks for gain in efficiency by comparing with the
standard Hotelling T 2.
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Next, we note that, as is the case in the usual Hotelling T 2 statistic, a whole
family of statistics arises by applying a linear transformation. We state this as
a corollary to the above theorem.
Corollary 1: Assume conditions (1) and (2) above except without any restric-
tion on d and ng relative to oneanother. Consider the matrixM , which is chosen
to be of dimension q × d of rank r < ming ng. Then we can replace Y¯g, Sg,Λ
and d by MY¯g,MSgM
′,MΛM ′ and r in the theorem above and the conclusions
still follow.
The above theorem and its corollary are used to test a variety of null hy-
potheses, H0 : Mµ = 0 where µ = EY1. There are three natural choices for
M . Call these the “zero means” contrast, Mµ0, the “equal means” contrast,
Mµeq,and the “no trend” contrast, Mtrend0. Specifically, these are given by:
Mµ0 = Id, which requires that n > d, Mµeq = Id −
1
n1d 1
′
d, which requires that
n > d−1, andMtrend0 = {(u u
′)−1 u′}2, u = [1d, [0, 1, . . . , d−1]
′], which requires
that n > 1 and d > 2. The application of these results to testing hypotheses in
the analysis of both cDNA and oligonucleotide arrays will be clearly laid out in
the section which follows.
Notice in the definition of the statistics ShHT2g given above in 1, the param-
eter matrix, Λ, and the shape parameter, ν arising in the prior distribution of
Σ| g are assumed to be “known”. The next result is used to estimate Λ and ν
via maximum likelihood using the data the Sg, g = 1, . . . , G which under our
model are i.i.d. draws from the density given below in 2.
Theorem 2: Under the conditions of theorem 1, Ag = (n − 1)Sg has density
function equal to
f(A) =
Γd
(
ν+ng−d−2
2
)
Γd
(
ng−1
2
)
Γd
(
νg−d−1
2
) |Λ|(ν−d−1)/2 |A|(ng−d−2)/2
|Λ +A|(ν+ng−d−2)/2
. (2)
4 Other statistics under study
Here we will be using the notation of theorem 1 and its corollary above. In
addition to the quantities presented there, we write Yg for the ngd dimensional
column vector containing the observations {Yg,i,k : i = 1, . . . , ng, k = 1, . . . , d}
stacked by replicate within component, and Rg = (n − 1)
∑d
k=1 Sg,k,k for the
total within group sum of squares. Notice that within a particular set of dis-
tributional assumptions on Yg and a particular framework for constructing test
statistics, a variety of hypothesis tests are made possible through the applica-
tion the appropriate linear transformation to the data. That being said, we
restrict attention in this portion of exposition to tests of zero group means. The
simplist statistic is the standard F-statistic, which assumes that the sequence
of random vectors {Yg,i : i = 1, . . . , ng} is stochastically independent with
identical distribution given by independent normals having component means
µg,1, . . . , µg,d and common variance σ
2
g . Under the null hypothesis and under
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these distributional assumptions,
UT2g =
d(ng − 1)
ngd
Y ′gYg
Rg
(3)
has an f distribution with ngd and d(ng− 1) degrees of freedom. This standard
f -statistic was modified using a univariate empirical bayes estimate of the per-
gene common variance in [12]. Similar results and extensions were presented
in [7], [2], and [6]. The distributional assumptions required by that method
are, conditional upon σ2g , identical to the above. The difference is that σ
2
g has
an inverse gamma distribution with shape parameter 2s and rate parameter 2r
which results in exchangeable dependence among replicates i of the experiment.
Under the null hypothesis and under these assumptions,
ShUT2g =
2s+ d(ng − 1)
ngd
Y ′gYg
2r +Rg
(4)
has an f distribution with ngd and 2s+ d(ng − 1) degrees of freedom. This is
deduced via an argument almost identical to that in [12]. This statistic is the
univariate analogue of the statistic presented here.
If we assume instead, that the sequence of random vectors {Yg,i : i =
1, . . . , ng} is stochastically independent with identical distribution multivari-
ate normal with mean vector components µg,1, . . . , µg,d and variance covariance
matrix Σ| g then under the null hypothesis and under these distributional as-
sumptions,
HT2g =
ng − d
d
ng
ng − 1
Y¯ ′gS
−1
g Y¯g (5)
has an f distribution with d and ng − 1 degrees of freedom (see, for example,
[9]).
5 Software: R package SharedHT2
An R package for conducting analyses using the methods of this paper has
been created and is available for download at the CRAN website. One of the
most desirable facets of this package is that it is entirely coded in C with
minimal processing done in R. The main function “EB.Anova” fits the mul-
tivariate normal/inverse Wishart model to micro-array data and calculates the
per gene ShHT 2 statistics shown in formula 1 in theorem 1 when the argu-
ment “Var.Struct” is set to “general”. In addition, the same function can be
used to fit the normal/inverse gamma model of [12] and calculate the ShUT 2
statistics shown in formula 4 in the preceding section by setting the argument
“Var.Struct” to “simple”. In both cases, the models are fit using maximum
likelihood estimation. There is flexibility in the choice of hypothesis test via
setting the argument “H0” to one of the following choices. Under the “general”
variance structure option,
7
(i) if n > d, the H0=“zero.means” null may be tested.
(ii) if n > d− 1, the H0=“equal.means” null may be tested.
(iii) if n > 1, H0=“no.trend” null may be tested, but of course this only makes
sense if d > 2.
(iv) The user may also set H0 to an custom contrast matrix of dimension r×d
and of rank r.
Under the “simple” variance structure option, any of the above null hypotheses
may be tested as long as n > 1. By default, “H0” is set to “equal.means”. The
package uses S3 classes and has several other nice features. For example if the
data comes from an affy experiment and the rows are named after the affy gene
identifiers, then a genelist sorted on p-value can be browsed in the html viewer
with links to the Weizmann Institute’s “GeneCards” database. Additionally,
the simulation study presented in the following section may be repeated using
included functions. It is worth mention here that these simulations were only
made possible by migrating the entire procedure including the loop over sim-
ulation replicates, into C. The interested reader is encouraged to browse the
documentation.
6 Comparison with other approaches–simulation
study
We conducted a simulation study in order to compare the operating characteris-
tics of the proposed shared variance Hotelling T 2 statistic (ShHT2) in expression
1 with those of the three other statistics, 3, 4, 5 that were described in a pre-
ceding section. In all cases the test was relative to the null hypothesis of group
means identically zero, with two groups.
The first simulation study was conducted by generating data from the multi-
variate normal/inverse Wishart model with d = 2 groups and ng = 3 replicated
observations for each of G=12625 genes, using values for Λ and ν that were
obtained in the analysis of the oligonucleotide array data (see below for further
details). One hundred of the genes were designated as “true positives” by giv-
ing them non-zero group specific means that were chosen in the following way.
First, a value of θ was chosen so that
0.90 = F6,4,3θ(F
−1
6,4 (1− 0.0026))
i.e., so that the UT2 statistic would have power 90% at a type I error of 0.26%
to reject the null hypothesis of zero group means. This value of θ = 7.5 was
then multiplied by the average per group standard deviation calculated under
the multivariate normal/inverse Wishart model, i.e. 1ν−2d−2diag
[
Λ
]
to arrive at
the two group specific means applied identically to each of the ten designated
genes.
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In order to study the robustness of the test statistic to lack of model assump-
tions, a second simulation study was conducted using a Normal-2 component
mixed inverse Wishart distribution. Specifically, the data are i.i.d. multivariate
normal but the prior distribution on the random variance/covariance matrix
is a mixture of two inverse Wisharts, having shape parameters ν1 and ν2 and
common rate matrix λ. The mixing proportion, f and shape parameters ν1
and ν2 were chose so that the expected value of Sg, the per gene empirical
covariance matrix, would remain identical its value under the multivariate nor-
mal/inverse Wishart model used previously, Λν−2d−1 . The values used were
f = 0.2, ν1 = 18.4067, and ν2 = 6.77542. Once again, one hundred genes were
designated as “true positives” by assigning means as above.
The simulation results were summarized in two ways. The first method,
shown in tables 6 and 6, used the Benjamini-Hochberg FDR stepdown pro-
cedure to set the significance criterion. In each simulation replicate, the four
listed statistics and corresponding p-values were calculated for each of the 12625
genes. Next, for each statistic, the list was sorted on corresponding p-value and
the row containing the largest p-value not exceeding (rank)FDR/12625 and all
rwos above it were marked significant. The true positive rate was derived as
the number of genes called significant as a proportion of those truely differen-
tially expressed, i.e. 100. The false positive rate was derived as the number of
genes called significant not among those 100. These were averaged over simula-
tion replicates yielding emprical true positive rates (eTPR) and empirical false
positive rate (eFPR). In table 6 is shown results for the data simulated from
the normal/Inverse Wishart model. The leftmost column is the nominal false
discovery rate, FDR, used in setting the significance criterion. The next eight
columns are the empirical true positive and false positive rates for each of the
four benchmarked statistics.
Results corresponding to data simulated from the multivariate normal/inverse
Wishart model are shown in table 6. In the case of the proposed statistic,
ShHT 2, the eFPR coincides within simulation error with the FDR. That is be-
cause the p-values are derived via the F-distribution listed in theorem 1, which
assumes the data arise from a multivariate normal/inverse Wishart distribu-
tion. Notice as well that the eTPR is quite high in the 90’s at the low FDR
of 0.05. The other three statistics benchmarked a clearly inferior. First, HT 2,
thestandard hotelling T 2, is nearly uninformative, displaying an eTPR of 100%
at all values of FDR with correspondingly high eFPR ranging upwards from
85%. The shrinkage variance F-statistic, ShUT 2, is overly concervative, with
eFPR equal to zero within simulation error and eTPR ranging from 20% to
50%. Finally, the ordinary F-statistic, UT 2, is overly conservative at the lower
FDR’s of 5% and 10%, but then uninformative at the higher FDR’s of 15%,
20% and 25%.
The results corresponding to data simulated from the normal/mixed inverse
Wishart model are shown in 6. The only notable difference relateive to remarks
made above is that control over the FDR is now lost, as the eFPR no longer
agrees with the FDR. Still, if the simulation model can be considered an
extreme departure from the model assumptions then use of the FDR=5% which
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gives eFPR = 12% and eTPR = 94% should be acceptible.
On the other hand one may wish to dispesne with any attempts at control-
ing the false discovery rate at all, and instead, rely on the statistic’s ability to
provide a more informative ordering. In this case, we simply decide how many
genes we wish to call significant and draw the line there. For the second method
of summarizing the simulation results the eTPR and eFPR were derived this
time using, consecutively, each of the values of the statistic as the significance
criterion. The results for data obeying model assumptions are shown in figures
1, and for data not obeying model assumptions in figure 2. It is clear that our
proposed statistic, ShHT 2, outperforms the others when the data obeys the
model assumptions presented in theorem 1. Although this advantage is atten-
uated when the data does not obey model assumptions, there is still a modest
advantage. For this reason we recommend its use over the one dimensional test,
ShUT 2 and the related SAM of [11].
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Table 1
ShHT2 HT2 ShUT2 UT2
FDR TPF FPF TPF FPF TPF FPF TPF FPF
0.05 0.929 0.045 1.00 0.857 0.204 0.00 0.014 0.00
0.10 0.964 0.093 1.00 0.927 0.341 0.00 0.079 0.00
0.15 0.976 0.141 1.00 0.951 0.424 0.00 1.00 0.992
0.20 0.983 0.192 1.00 0.963 0.480 0.00 1.00 0.992
0.25 0.987 0.242 1.00 0.970 0.526 0.00 1.00 0.992
Table 2
ShHT2 HT2 ShUT2 UT2
FDR TPF FPF TPF FPF TPF FPF TPF FPF
0.05 0.944 0.123 1.00 0.863 0.424 0.00 0.343 0.000
0.10 0.968 0.223 1.00 0.929 0.556 0.00 0.593 0.000
0.15 0.976 0.307 1.00 0.951 0.626 0.00 1.000 0.992
0.20 0.981 0.378 1.00 0.963 0.671 0.00 1.000 0.992
0.25 0.985 0.442 1.00 0.970 0.706 0.00 1.000 0.992
7 Application: Two Case Studies
As mentioned in the introductory section, these techniques were used to an-
alyze two datasets, the first from a spotted cDNA array experiment and the
second from an oligonucleotide array experiment. In the first experiment, sev-
eral colonies of LnCAP cells were allowed to grow for 24 hours in the presence
of either control medium or 1µM, 5µM, or 25µM of genestein. Messenger RNA
(mRNA) isolated from each of the treated groups was hybridized onto the green
channel of a corresponding micro-array, while mRNA isolated from the control
treated colony was hybridized onto the red channel of each micro-array. This
experiment was conducted independently and in identical fashion on three sepa-
rate dates. Systematic variability occuring from array to array and within array
were adjusted out in the manner suggested by [3]. Within each experimental
replicate and for each gene, the log base two of the ratio of normalized green to
red channel expression values were calculated and used in subsequent analysis.
Since the group dimension was d = 3 and the sample size was n = 3 then a test
of the zero means null using the ShHT 2 statistic was not possible. However,
we tested the equal means null using both the ShUT 2 statistic and the ShHT 2
statistic.
The second study was an oligonucleotide micro-array experiment studying
the effects of two hormones, dehydroepiandrosterone (DHEA) and dihyrotestos-
terone (DHT), on gene expression in the LnCAP line. Again, several batches
of colonies were treated with either DHEA, dhT, or control media and allowed
to grow for 24 hours. mRNA isolated from each of the two treated colonies as
well as from the control treated colony was hybridized onto one of three cor-
responding single channel oligonucleotide arrays. The raw image files, in CEL
format, were imported into the R statistical computing platform [10]. For each
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gene, the probe set was summarized into a model based gene expression index
[5], using the Bioconductor suite of add-on libraries for R [4]. Within each ex-
perimental replicate and for each gene, the log base two of the expression ratios
of treatment to control were calculated and used in subsequent analysis. The
research questions here were (i) whether there was differential expression be-
tween treatment and control under treatment with either hormone, any of the
three conditions, and if so (ii) was there differential expression between the two
treatments.
Table 7
Gene dhea dht stat p-val FDR=0.10
1 34319 at 1.690 4.400 273.0 1.902e-07 7.129e-06
2 36658 at 2.440 2.790 90.9 8.665e-06 1.426e-05
3 33998 at 0.519 0.275 85.1 1.084e-05 2.139e-05
4 38827 at 1.310 1.840 64.1 2.836e-05 2.851e-05
8 Appendix Proofs of theorems
Proof of theorem 1: In the following, for any symmetric matrix with spectral
decomposition A = QDQ′, let A
1
2
s = QD
1
2Q′ be the symmetric square root of
A. A
−
1
2
s is the symmetric square root of A−1. Square root matrices without the
subscript s are considered Cholesky square roots, but will not appear in this
manuscript. First, rewrite T 2 as follows:
T 2 = n
(
Σ|
−
1
2
s Y¯
)(
Σ|
−
1
2
s ΛΣ|
−
1
2
s + (n− 1)Σ|
−
1
2
s SΣ|
−
1
2
s
)
−1 (
Σ|
−
1
2
s Y¯
)
D
= n
(
Σ|
−
1
2
s Y¯
)(
Λ
1
2
s Σ|
−1
Λ
1
2
s + (n− 1)Σ|
−
1
2
s SΣ|
−
1
2
s
)
−1 (
Σ|
−
1
2
s Y¯
)
,
where equality in distribution follows from the fact that because Σ|
−
1
2
s ΛΣ|
−
1
2
s and
Λ
1
2
s Σ|
−1
Λ
1
2
s are both positive definite and symetric, it follows from theorem A9.9
of [9] that they are an orthogonal similarity transformation of eachother and
since the latter has a Wishart distribution (see below), equality in distributions
follows from the invariance of the Wishart distribution to orthogonal similarity
transformations.
Next we make the following observations:
1. (n−1)Σ|
−
1
2
s SΣ|
−
1
2
s has the Wishartd(n−1, Id) distribution and is therefore,
independent of Σ| . This is because the conditional distribution of (n− 1)S
given Σ| is Wishartd(n− 1,Σ| ).
2. Λ
1
2
s Σ|
−1
Λ
1
2
s has the Wishartd(ν − d− 1, Id) distribution, because Σ|
−1
has
the Wishartd(ν − d− 1,Λ
−1).
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Therefore, the sum,
V = Λ
1
2
s Σ|
−1
Λ
1
2
s + (n− 1)Σ|
−
1
2
s SΣ|
−
1
2
s
has the Wishartd(ν + n − d − 2, Id) distribution. Next, put Z = Σ|
−
1
2
s Y¯ and
rewrite T 2 as
T 2 = nZ ′V −1Z =
nZ ′Z
Z′Z
Z′V −1Z
.
Notice that since Z has been rescaled, it is independant of Σ| . Next, because
Z is the sample mean, it is independant of the sample covariance matrix, S.
Thus Z and V are independant. Next, it follows from theorem 3.2.12 of [9], the
denominator is distributed χ2ν+n−2d−1 and independent of the Z. Because the
numerator is χ2d, it follows that T
2 ν+n−2d−1
d has the Fd,ν+n−2d−1 distribution.
Proof of theorem 2: As stated above, the conditional distribution of A =
(n− 1)S given Σ| is Wishartd(n− 1,Σ| ) which has density:
fW
d,n−1,Σ|
(A) = Γd
(
n− 1
2
)
−1
|A|
(n−d−2)/2
2d(n−1)/2
∣∣Σ| ∣∣(n−1)/2 etr
(
−
1
2
Σ|
−1
A
)
while Σ| has the InvWishartd(ν,Λ) distribution, which has density:
fW
−1
d,ν,Λ(Σ| ) = Γd
(
ν − d− 1
2
)
−1
|Λ|
(ν−d−1)/2
2d(ν−d−1)/2
∣∣Σ| ∣∣ν/2 etr
(
−
1
2
Σ|
−1
Λ
)
Taking the product of the two above densities and reorganizing factors yeilds:
fW
d,n−1,Σ|
(A)fW
−1
d,ν,Λ(Σ| ) = Γd
(
ν + n− d− 2
2
)
−1
|Λ +A|
(ν+n−d−2)/2
2d(ν+n−d−2)/2
∣∣Σ| ∣∣(ν+n−1)/2 etr
(
−
1
2
Σ|
−1
(Λ +A)
)
Γd
(
ν+n−d−2
2
)
Γd
(
n−1
2
)
Γd
(
ν−d−1
2
) |Λ|(ν−d−1)/2 |A|(n−d−2)/2
|Λ +A|
(ν+n−d−2)/2
.
Thus, the posterior distribution of Σ| given A = (n− 1)S is
InvWishartd(ν + n− 1,Λ + (n− 1)S), and so the distribution of A = (n− 1)S
is the one given in expression 2.
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